Industry Research Reports

Home > Reports > Chemical & Material > Imipenem for Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Imipenem for Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Chemical & Material

Published Date: 2024-02-23

Pages: 104 Pages

Report ld: 2573904

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Imipenem for Injection was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

MARKET SEGMENTATION

By Company

Savior Lifetec Corporation
ACS Dobfar
Shenzhen Haibin Pharmaceutical
Zhuhai United Laboratories
Zhejiang Jiuzhou Pharmaceutical
Sun Pharma
Kaliberr Labs
Jeil Pharmaceutical

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Purity >98%
Purity >99%

Segment by Application

Intravenous Injection
Intramuscular Injection

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Imipenem for Injection, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Imipenem for Injection by region & country, by Type, and by Application.

The Imipenem for Injection market size, estimations, and forecasts are provided in terms of sales volume (Ton) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Imipenem for Injection.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Imipenem for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Imipenem for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Imipenem for Injection in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Imipenem for Injection Product Introduction

1.2 Global Imipenem for Injection Market Size Forecast

1.2.1 Global Imipenem for Injection Sales Value (2019-2030)

1.2.2 Global Imipenem for Injection Sales Volume (2019-2030)

1.2.3 Global Imipenem for Injection Sales Price (2019-2030)

1.3 Imipenem for Injection Market Trends & Drivers

1.3.1 Imipenem for Injection Industry Trends

1.3.2 Imipenem for Injection Market Drivers & Opportunity

1.3.3 Imipenem for Injection Market Challenges

1.3.4 Imipenem for Injection Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Imipenem for Injection Players Revenue Ranking (2023)

2.2 Global Imipenem for Injection Revenue by Company (2019-2024)

2.3 Global Imipenem for Injection Players Sales Volume Ranking (2023)

2.4 Global Imipenem for Injection Sales Volume by Company Players (2019-2024)

2.5 Global Imipenem for Injection Average Price by Company (2019-2024)

2.6 Key Manufacturers Imipenem for Injection Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Imipenem for Injection Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Imipenem for Injection

2.9 Imipenem for Injection Market Competitive Analysis

2.9.1 Imipenem for Injection Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Imipenem for Injection Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imipenem for Injection as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Purity >98%

3.1.2 Purity >99%

3.2 Global Imipenem for Injection Sales Value by Type

3.2.1 Global Imipenem for Injection Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Imipenem for Injection Sales Value, by Type (2019-2030)

3.2.3 Global Imipenem for Injection Sales Value, by Type (%) (2019-2030)

3.3 Global Imipenem for Injection Sales Volume by Type

3.3.1 Global Imipenem for Injection Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Imipenem for Injection Sales Volume, by Type (2019-2030)

3.3.3 Global Imipenem for Injection Sales Volume, by Type (%) (2019-2030)

3.4 Global Imipenem for Injection Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Intravenous Injection

4.1.2 Intramuscular Injection

4.2 Global Imipenem for Injection Sales Value by Application

4.2.1 Global Imipenem for Injection Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Imipenem for Injection Sales Value, by Application (2019-2030)

4.2.3 Global Imipenem for Injection Sales Value, by Application (%) (2019-2030)

4.3 Global Imipenem for Injection Sales Volume by Application

4.3.1 Global Imipenem for Injection Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Imipenem for Injection Sales Volume, by Application (2019-2030)

4.3.3 Global Imipenem for Injection Sales Volume, by Application (%) (2019-2030)

4.4 Global Imipenem for Injection Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Imipenem for Injection Sales Value by Region

5.1.1 Global Imipenem for Injection Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Imipenem for Injection Sales Value by Region (2019-2024)

5.1.3 Global Imipenem for Injection Sales Value by Region (2025-2030)

5.1.4 Global Imipenem for Injection Sales Value by Region (%), (2019-2030)

5.2 Global Imipenem for Injection Sales Volume by Region

5.2.1 Global Imipenem for Injection Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Imipenem for Injection Sales Volume by Region (2019-2024)

5.2.3 Global Imipenem for Injection Sales Volume by Region (2025-2030)

5.2.4 Global Imipenem for Injection Sales Volume by Region (%), (2019-2030)

5.3 Global Imipenem for Injection Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Imipenem for Injection Sales Value, 2019-2030

5.4.2 North America Imipenem for Injection Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Imipenem for Injection Sales Value, 2019-2030

5.5.2 Europe Imipenem for Injection Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Imipenem for Injection Sales Value, 2019-2030

5.6.2 Asia Pacific Imipenem for Injection Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Imipenem for Injection Sales Value, 2019-2030

5.7.2 South America Imipenem for Injection Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Imipenem for Injection Sales Value, 2019-2030

5.8.2 Middle East & Africa Imipenem for Injection Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Imipenem for Injection Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Imipenem for Injection Sales Value

6.2.1 Key Countries/Regions Imipenem for Injection Sales Value, 2019-2030

6.2.2 Key Countries/Regions Imipenem for Injection Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Imipenem for Injection Sales Value, 2019-2030

6.3.2 United States Imipenem for Injection Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Imipenem for Injection Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Imipenem for Injection Sales Value, 2019-2030

6.4.2 Europe Imipenem for Injection Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Imipenem for Injection Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Imipenem for Injection Sales Value, 2019-2030

6.5.2 China Imipenem for Injection Sales Value by Type (%), 2023 VS 2030

6.5.3 China Imipenem for Injection Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Imipenem for Injection Sales Value, 2019-2030

6.6.2 Japan Imipenem for Injection Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Imipenem for Injection Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Imipenem for Injection Sales Value, 2019-2030

6.7.2 South Korea Imipenem for Injection Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Imipenem for Injection Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Imipenem for Injection Sales Value, 2019-2030

6.8.2 Southeast Asia Imipenem for Injection Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Imipenem for Injection Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Imipenem for Injection Sales Value, 2019-2030

6.9.2 India Imipenem for Injection Sales Value by Type (%), 2023 VS 2030

6.9.3 India Imipenem for Injection Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Savior Lifetec Corporation

7.1.1 Savior Lifetec Corporation Company Information

7.1.2 Savior Lifetec Corporation Introduction and Business Overview

7.1.3 Savior Lifetec Corporation Imipenem for Injection Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Savior Lifetec Corporation Imipenem for Injection Product Offerings

7.1.5 Savior Lifetec Corporation Recent Development

7.2 ACS Dobfar

7.2.1 ACS Dobfar Company Information

7.2.2 ACS Dobfar Introduction and Business Overview

7.2.3 ACS Dobfar Imipenem for Injection Sales, Revenue and Gross Margin (2019-2024)

7.2.4 ACS Dobfar Imipenem for Injection Product Offerings

7.2.5 ACS Dobfar Recent Development

7.3 Shenzhen Haibin Pharmaceutical

7.3.1 Shenzhen Haibin Pharmaceutical Company Information

7.3.2 Shenzhen Haibin Pharmaceutical Introduction and Business Overview

7.3.3 Shenzhen Haibin Pharmaceutical Imipenem for Injection Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Shenzhen Haibin Pharmaceutical Imipenem for Injection Product Offerings

7.3.5 Shenzhen Haibin Pharmaceutical Recent Development

7.4 Zhuhai United Laboratories

7.4.1 Zhuhai United Laboratories Company Information

7.4.2 Zhuhai United Laboratories Introduction and Business Overview

7.4.3 Zhuhai United Laboratories Imipenem for Injection Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Zhuhai United Laboratories Imipenem for Injection Product Offerings

7.4.5 Zhuhai United Laboratories Recent Development

7.5 Zhejiang Jiuzhou Pharmaceutical

7.5.1 Zhejiang Jiuzhou Pharmaceutical Company Information

7.5.2 Zhejiang Jiuzhou Pharmaceutical Introduction and Business Overview

7.5.3 Zhejiang Jiuzhou Pharmaceutical Imipenem for Injection Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Zhejiang Jiuzhou Pharmaceutical Imipenem for Injection Product Offerings

7.5.5 Zhejiang Jiuzhou Pharmaceutical Recent Development

7.6 Sun Pharma

7.6.1 Sun Pharma Company Information

7.6.2 Sun Pharma Introduction and Business Overview

7.6.3 Sun Pharma Imipenem for Injection Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Sun Pharma Imipenem for Injection Product Offerings

7.6.5 Sun Pharma Recent Development

7.7 Kaliberr Labs

7.7.1 Kaliberr Labs Company Information

7.7.2 Kaliberr Labs Introduction and Business Overview

7.7.3 Kaliberr Labs Imipenem for Injection Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Kaliberr Labs Imipenem for Injection Product Offerings

7.7.5 Kaliberr Labs Recent Development

7.8 Jeil Pharmaceutical

7.8.1 Jeil Pharmaceutical Company Information

7.8.2 Jeil Pharmaceutical Introduction and Business Overview

7.8.3 Jeil Pharmaceutical Imipenem for Injection Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Jeil Pharmaceutical Imipenem for Injection Product Offerings

7.8.5 Jeil Pharmaceutical Recent Development

8 Industry Chain Analysis

8.1 Imipenem for Injection Industrial Chain

8.2 Imipenem for Injection Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Imipenem for Injection Sales Model

8.5.2 Sales Channel

8.5.3 Imipenem for Injection Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Imipenem for Injection Market Trends

Table 2. Imipenem for Injection Market Drivers & Opportunity

Table 3. Imipenem for Injection Market Challenges

Table 4. Imipenem for Injection Market Restraints

Table 5. Global Imipenem for Injection Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Imipenem for Injection Revenue Market Share by Company (2019-2024)

Table 7. Global Imipenem for Injection Sales Volume by Company (2019-2024) & (Ton)

Table 8. Global Imipenem for Injection Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Imipenem for Injection Price by Company (2019-2024) & (US$/Ton)

Table 10. Key Manufacturers Imipenem for Injection Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Imipenem for Injection Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Imipenem for Injection

Table 13. Global Imipenem for Injection Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imipenem for Injection as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Imipenem for Injection Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Imipenem for Injection Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Imipenem for Injection Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Imipenem for Injection Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Imipenem for Injection Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Imipenem for Injection Sales Volume by Type: 2019 VS 2023 VS 2030 (Ton)

Table 22. Global Imipenem for Injection Sales Volume by Type (2019-2024) & (Ton)

Table 23. Global Imipenem for Injection Sales Volume by Type (2025-2030) & (Ton)

Table 24. Global Imipenem for Injection Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Imipenem for Injection Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Imipenem for Injection Price by Type (2019-2024) & (US$/Ton)

Table 27. Global Imipenem for Injection Price by Type (2025-2030) & (US$/Ton)

Table 28. Global Imipenem for Injection Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Imipenem for Injection Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Imipenem for Injection Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Imipenem for Injection Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Imipenem for Injection Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Imipenem for Injection Sales Volume by Application: 2019 VS 2023 VS 2030 (Ton)

Table 34. Global Imipenem for Injection Sales Volume by Application (2019-2024) & (Ton)

Table 35. Global Imipenem for Injection Sales Volume by Application (2025-2030) & (Ton)

Table 36. Global Imipenem for Injection Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Imipenem for Injection Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Imipenem for Injection Price by Application (2019-2024) & (US$/Ton)

Table 39. Global Imipenem for Injection Price by Application (2025-2030) & (US$/Ton)

Table 40. Global Imipenem for Injection Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Imipenem for Injection Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Imipenem for Injection Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Imipenem for Injection Sales Value by Region (2019-2024) & (%)

Table 44. Global Imipenem for Injection Sales Value by Region (2025-2030) & (%)

Table 45. Global Imipenem for Injection Sales Volume by Region (Ton): 2019 VS 2023 VS 2030

Table 46. Global Imipenem for Injection Sales Volume by Region (2019-2024) & (Ton)

Table 47. Global Imipenem for Injection Sales Volume by Region (2025-2030) & (Ton)

Table 48. Global Imipenem for Injection Sales Volume by Region (2019-2024) & (%)

Table 49. Global Imipenem for Injection Sales Volume by Region (2025-2030) & (%)

Table 50. Global Imipenem for Injection Average Price by Region (2019-2024) & (US$/Ton)

Table 51. Global Imipenem for Injection Average Price by Region (2025-2030) & (US$/Ton)

Table 52. Key Countries/Regions Imipenem for Injection Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Imipenem for Injection Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Imipenem for Injection Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Imipenem for Injection Sales Volume, (2019-2024) & (Ton)

Table 56. Key Countries/Regions Imipenem for Injection Sales Volume, (2025-2030) & (Ton)

Table 57. Savior Lifetec Corporation Company Information

Table 58. Savior Lifetec Corporation Introduction and Business Overview

Table 59. Savior Lifetec Corporation Imipenem for Injection Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 60. Savior Lifetec Corporation Imipenem for Injection Product Offerings

Table 61. Savior Lifetec Corporation Recent Development

Table 62. ACS Dobfar Company Information

Table 63. ACS Dobfar Introduction and Business Overview

Table 64. ACS Dobfar Imipenem for Injection Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 65. ACS Dobfar Imipenem for Injection Product Offerings

Table 66. ACS Dobfar Recent Development

Table 67. Shenzhen Haibin Pharmaceutical Company Information

Table 68. Shenzhen Haibin Pharmaceutical Introduction and Business Overview

Table 69. Shenzhen Haibin Pharmaceutical Imipenem for Injection Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 70. Shenzhen Haibin Pharmaceutical Imipenem for Injection Product Offerings

Table 71. Shenzhen Haibin Pharmaceutical Recent Development

Table 72. Zhuhai United Laboratories Company Information

Table 73. Zhuhai United Laboratories Introduction and Business Overview

Table 74. Zhuhai United Laboratories Imipenem for Injection Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 75. Zhuhai United Laboratories Imipenem for Injection Product Offerings

Table 76. Zhuhai United Laboratories Recent Development

Table 77. Zhejiang Jiuzhou Pharmaceutical Company Information

Table 78. Zhejiang Jiuzhou Pharmaceutical Introduction and Business Overview

Table 79. Zhejiang Jiuzhou Pharmaceutical Imipenem for Injection Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 80. Zhejiang Jiuzhou Pharmaceutical Imipenem for Injection Product Offerings

Table 81. Zhejiang Jiuzhou Pharmaceutical Recent Development

Table 82. Sun Pharma Company Information

Table 83. Sun Pharma Introduction and Business Overview

Table 84. Sun Pharma Imipenem for Injection Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 85. Sun Pharma Imipenem for Injection Product Offerings

Table 86. Sun Pharma Recent Development

Table 87. Kaliberr Labs Company Information

Table 88. Kaliberr Labs Introduction and Business Overview

Table 89. Kaliberr Labs Imipenem for Injection Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 90. Kaliberr Labs Imipenem for Injection Product Offerings

Table 91. Kaliberr Labs Recent Development

Table 92. Jeil Pharmaceutical Company Information

Table 93. Jeil Pharmaceutical Introduction and Business Overview

Table 94. Jeil Pharmaceutical Imipenem for Injection Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 95. Jeil Pharmaceutical Imipenem for Injection Product Offerings

Table 96. Jeil Pharmaceutical Recent Development

Table 97. Key Raw Materials Lists

Table 98. Raw Materials Key Suppliers Lists

Table 99. Imipenem for Injection Downstream Customers

Table 100. Imipenem for Injection Distributors List

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Imipenem for Injection Product Picture

Figure 2. Global Imipenem for Injection Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Imipenem for Injection Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Imipenem for Injection Sales Volume (2019-2030) & (Ton)

Figure 5. Global Imipenem for Injection Sales Price (2019-2030) & (US$/Ton)

Figure 6. Imipenem for Injection Report Years Considered

Figure 7. Global Imipenem for Injection Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Imipenem for Injection Players Sales Volume Ranking (2023) & (Ton)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Imipenem for Injection Revenue in 2023

Figure 10. Imipenem for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Purity >98% Picture

Figure 12. Purity >99% Picture

Figure 13. Global Imipenem for Injection Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Imipenem for Injection Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Imipenem for Injection Sales Volume by Type (2019 VS 2023 VS 2030) & (Ton)

Figure 16. Global Imipenem for Injection Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Imipenem for Injection Price by Type (2019-2030) & (US$/Ton)

Figure 18. Product Picture of Intravenous Injection

Figure 19. Product Picture of Intramuscular Injection

Figure 20. Global Imipenem for Injection Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Imipenem for Injection Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Imipenem for Injection Sales Volume by Application (2019 VS 2023 VS 2030) & (Ton)

Figure 23. Global Imipenem for Injection Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Imipenem for Injection Price by Application (2019-2030) & (US$/Ton)

Figure 25. North America Imipenem for Injection Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Imipenem for Injection Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Imipenem for Injection Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Imipenem for Injection Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Imipenem for Injection Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Imipenem for Injection Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Imipenem for Injection Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Imipenem for Injection Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Imipenem for Injection Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Imipenem for Injection Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Imipenem for Injection Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Imipenem for Injection Sales Volume (%), (2019-2030)

Figure 37. United States Imipenem for Injection Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Imipenem for Injection Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Imipenem for Injection Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Imipenem for Injection Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Imipenem for Injection Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Imipenem for Injection Sales Value by Application (%), 2023 VS 2030

Figure 43. China Imipenem for Injection Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Imipenem for Injection Sales Value by Type (%), 2023 VS 2030

Figure 45. China Imipenem for Injection Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Imipenem for Injection Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Imipenem for Injection Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Imipenem for Injection Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Imipenem for Injection Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Imipenem for Injection Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Imipenem for Injection Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Imipenem for Injection Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Imipenem for Injection Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Imipenem for Injection Sales Value by Application (%), 2023 VS 2030

Figure 55. India Imipenem for Injection Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Imipenem for Injection Sales Value by Type (%), 2023 VS 2030

Figure 57. India Imipenem for Injection Sales Value by Application (%), 2023 VS 2030

Figure 58. Imipenem for Injection Industrial Chain

Figure 59. Imipenem for Injection Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Imipenem for Injection market? zhanKai

The top companies in the global Imipenem for Injection market are Savior Lifetec Corporation、ACS Dobfar、Shenzhen Haibin Pharmaceutical.

Related Reports

Imipenem for Injection- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Imipenem for Injection was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 129
USD 3950.00
(Single User License)
Global Imipenem for Injection Market Research Report 2026
The global Imipenem for Injection market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 132
USD 2900.00
(Single User License)
Global Imipenem for Injection Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Imipenem for Injection market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 149
USD 4900.00
(Single User License)
Imipenem for Injection- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Imipenem for Injection was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 94
USD 3950.00
(Single User License)
Global Imipenem for Injection Market Research Report 2025
The global market for Imipenem for Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 86
USD 2900.00
(Single User License)
Global Imipenem for Injection Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Imipenem for Injection market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 79
USD 4250.00
(Single User License)
Global Imipenem for Injection Market Insights, Forecast to 2030
The global Imipenem for Injection market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-08
Pages: 92
USD 4900.00
(Single User License)
Global Imipenem for Injection Market Research Report 2024
The global Imipenem for Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-06
Pages: 88
USD 2900.00
(Single User License)

Imipenem for Injection- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Imipenem for Injection was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 129
USD 3950.00 (Single User License)
Global Imipenem for Injection Market Research Report 2026
The global Imipenem for Injection market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 132
USD 2900.00 (Single User License)
Global Imipenem for Injection Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Imipenem for Injection market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 149
USD 4900.00 (Single User License)
Imipenem for Injection- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Imipenem for Injection was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 94
USD 3950.00 (Single User License)
Global Imipenem for Injection Market Research Report 2025
The global market for Imipenem for Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 86
USD 2900.00 (Single User License)
Global Imipenem for Injection Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Imipenem for Injection market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 79
USD 4250.00 (Single User License)
Global Imipenem for Injection Market Insights, Forecast to 2030
The global Imipenem for Injection market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-08
Pages: 92
USD 4900.00 (Single User License)
Global Imipenem for Injection Market Research Report 2024
The global Imipenem for Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-06
Pages: 88
USD 2900.00 (Single User License)